Cytoreductive surgery (CRS) combined with hyperthermic ... One study identified that colorectal cancer-related peritoneal metastases represent a distinct molecular subtype, known as Consensus ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Heat can kill cancer cells and may make chemotherapy more effective. It is most often used shortly after cytoreductive surgery has been completed for advanced peritoneal cancer. Immunotherapy may ...

ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines. To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery ...

The benefits of HIPEC include improved local control of cancer, reduced recurrence rates, and enhanced survival outcomes for ...

More information: EeeLN Buckarma et al, Cytoreduction and Hyperthermic Intraperitoneal Paclitaxel and Cisplatin for Gastric Cancer with Peritoneal Metastasis, Annals of Surgical Oncology (2023 ...

Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer. Among patients with platinum-sensitive peritoneal ...